Trending

Herpes Simplex Virus Treatment Market Future Scope (2023-2028): Key Factors, Status and Forecast

The Herpes Simplex Virus Treatment Market is expected to be around US$1800 million by 2028, registering a CAGR of 2.1%.

Market Research Engine has published a new report titled asHerpes Simplex Virus Treatment Market by Type (Herpes simplex virus-1 infection and Herpes simplex virus-2 infection), Drug type (Acyclovir, Valacyclovir and Famciclovir), Distribution channel (Hospital Pharmacies, Drug Store and Retail Pharmacies and Online Providers) and Geography (North America, Europe, APAC and RoW)-Forecast up to 2023 – 2028.”

Browse Full Report: https://www.marketresearchengine.com/herpes-simplex-virus-treatment-market

Herpes simplex virus is one of the highly usual sexually transmitted infections (STIs). It is a viral infection which affects humans. There are two forms of herpes simplex virus such as herpes simplex virus-1 (HSV-1) and herpes simplex virus-2 (HSV-2). HSV-1 is commonly related to oral herpes or cold sores. It may also leads to genital herpes through oral sex. HSV-2 is typically related to genital herpes and also causes oral herpes through oral sex. Rise and innovations in the pharmaceutical industry for the production of herpes simplex virus drugs generates an opportunity for the herpes simplex virus treatment market. Surge in awareness regarding the risks and problems of herpes simplex virus infection have resulted in an increased demand for effective treatments. This has resulted in high screening and diagnosis of HSV infection, further propelling the growth of the market. On the contrary, the social stigma related with sexually transmitted diseases, along with the surging product recalls are factors restraining market.

The Herpes Simplex Virus Treatment Market is expected to be around US$1800 million by 2028, registering a CAGR of 2.1%.

The Herpes Simplex Virus Treatment Market has been segmented below:

Herpes Simplex Virus Treatment Market by Type

  • Herpes simplex virus-1 infection
  • Herpes simplex virus-2 infection

Herpes Simplex Virus Treatment Market by Drug type

  • Acyclovir
  • Valacyclovir
  • Famciclovir

Herpes Simplex Virus Treatment Market by Distribution channel

  • Hospital pharmacies
  • Drug store and retail pharmacies
  • Online providers

Herpes Simplex Virus Treatment Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

The type segmentation is segmented as Herpes simplex virus-1 infection and Herpes simplex virus-2 infection. Herpes simplex virus-1 infection segment holds the vital share in the market. The rising incidence of Herpes simplex virus-1 infection is a key factor for the vital share of the segment. Furthermore, the rising pressure of Herpes simplex virus-1 encephalitis (HSE), a rare neurological disorder caused by the virus, is projected to augment the growth of the segment.

The Drug type segmentation is classified into Acyclovir, Valacyclovir and Famciclovir. The Valacyclovir segment has the maximum share in the market. This is owing to the availability, cost-effectiveness and effectiveness provided by valacyclovir in stopping the herpes virus from reproducing in the body, thus helping to reduce the symptoms of a herpes outbreak. Further, the valacyclovir is highly used for cold sores ascribed to its extensive absorption rate as acyclovir is broken down by the liver easily when consumed orally.

Based on distribution channel segmentation, the market is divided into Hospital Pharmacies, Drug Store and Retail Pharmacies and Online Providers. Hospital Pharmacies segment held the dominant share in the market. Since, these pharmacies are the major centers for the diagnosis and treatment of patients suffering from herpes infections in both developed and developing nations.

North America region is leading the market share on the basis of geography. The leading share of the segment is accredited to the increased consumption of branded herpes drugs, rising healthcare expenditure, rising introduction of generics, beneficial reimbursement policies and rising disease prevalence in the region are the key factors.

Furthermore, the increasing global health expenditure and government support to fulfill the surging demand for effective therapeutics are promoting companies to engage in creating new and innovative medicines. For example, in June 2021, Innovative Molecules GmbH, a Munich-based drug development company, declared positive results of its new drug candidate, IM-250, a second-generation helicase-primase inhibitor of HSV-1 and HSV-2 in different animal models of HSV. The company received USD 23.8 million in series A equity funding led by Life Sciences Partners and projects commencing Phase 1 clinical trials of IM-250 in late 2022 or early 2023.

The major leading companies of the herpes simplex virus treatment market are Viatris Inc., Amneal Pharmaceuticals LLC, Glenmark Pharmaceuticals Limited, Fresenius SE and Co. KGaA, Teva Pharmaceutical Industries Ltd., Abbott Laboratories, GlaxoSmithKline plc, Pfizer Inc., Novartis AG, Emcure Pharmaceuticals Limited

Therefore, the herpes simplex virus is the disease which does not have a complete treatment but the medications are available which are playing a significant part in suppressing the frequency and quantity of genital herpes among people. Moreover, the awareness has increased among people regarding the herpes simplex virus which has increased the market demand.

  • An exclusive analysis of all key geographical regions is included in the report which determines the potential opportunities in these regions.
  • Detailed information about the attributes which are generating growth in the herpes simplex virus treatment market in the forecast period.
  • An exact estimation of the herpes simplex virus treatment market share and its contribution to the parent market is provided in the report.
  • Further profiles of leading competitors and their dynamic strategies are also covered in the study.

Request Sample Report from here: https://www.marketresearchengine.com/herpes-simplex-virus-treatment-market

TABLE OF CONTENTS

  1.  Executive Summary
    2.    Industry Outlook
    2.1.    Industry Overview
    2.2.    Industry Trends
    3.    Market Snapshot
    4.    Market characteristics
    5.    Type: Market Size & Analysis
    6.    Drug type: Market Size & Analysis
    7.    Distribution channel: Market Size & Analysis
    7.1.    Overview
    7.2.    Hospital pharmacies
    7.3.    Drug store and retail pharmacies
    7.4.    Online providers
    8.    Geography: Market Size & Analysis
    8.1.    Overview
    8.2.    North America
    8.3.    Europe
    8.4.    Asia Pacific
    8.5.    Rest of the World
    9.    Competitive Landscape
    9.1.    Competitor Comparison Analysis
    9.2.    Market Developments
    9.2.1.    Mergers and Acquisitions, Legal, Awards, Partnerships
    9.2.2.    Product Launches and execution
    10.    Vendor Profiles
    10.1.    Viatris Inc.
    10.2.    Amneal Pharmaceuticals LLC
    10.3.    Glenmark Pharmaceuticals Limited
    10.4.    Fresenius SE and Co. KGaA
    10.5.    Teva Pharmaceutical Industries Ltd.
    10.5.1.    Overview
    10.5.2.    Financial Overview
    10.5.3.    Product Offerings
    10.5.4.    Developments
    10.5.5.    Business Strategy
    10.6.    Abbott Laboratories
    10.6.1.    Overview
    10.6.2.    Financial Overview
    10.6.3.    Product Offerings
    10.6.4.    Developments
    10.6.5.    Business Strategy
    10.7.    GlaxoSmithKline plc
    10.8.    Pfizer Inc.
    10.9.    Novartis AG
    10.10.    Emcure Pharmaceuticals Limited
    11.    Analyst Opinion
    12.    Annexure
    12.1.    Report Scope
    12.2.    Market Definitions
    12.3.    Research Methodology
    12.3.1.    Data Collation and In-house Estimation
    12.3.2.    Market Triangulation
    12.3.3.    Forecasting
    12.4.    Report Assumptions
    12.5.    Declarations
    12.6.    Stakeholders
    12.7.    Abbreviations

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Other Related Market Research Reports:

Non-Small Cell Lung Cancer Market Size predicts favorable growth and forecast 2023 – 2026

Health and Wellness Market Future Scope (2024-2027): Key Factors, Status and Forecast

Dystonia Drugs Market Future Scope (2024-2027): Key Factors, Status and Forecast

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: [email protected]

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

Related Articles

Back to top button